The prostate cancer genome: perspectives and potential
Christopher E Barbieri1, Scott A Tomlins2
1Department of Urology, Weill Medical College of Cornell University, New York, NY; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY.
Urologic Oncology
|November 19, 2013
Summary
Prostate cancer
Area of Science:
- Genomic research in oncology
- Molecular pathology of cancer
Background:
- Prostate cancer exhibits significant clinical variability.
- Genomic heterogeneity contributes to unpredictable disease behavior.
Purpose of the Study:
- To review genomic alterations in prostate cancer.
- To explore their diagnostic and prognostic potential.
Main Methods:
- Literature review focusing on somatic alterations in prostate cancer.
Main Results:
- Common tumorigenesis pathways (PI3K, cell cycle, chromatin regulation) are dysregulated.
- Prostate cancer-specific alterations include androgen signaling, ETS gene fusions, and SPOP mutations.
- Molecular profiling can subdivide prostate cancer based on genetic alterations.
Conclusions:
- Prostate cancer may be classified into molecular subtypes.
- These subtypes could have distinct risk profiles and therapeutic strategies.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
6.1K
6.1K
Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
2.7K
2.7K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


